Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: The TAXUS V ISR trial

European Heart Journal

Volumn 29, Issue 13, 2008, Pages 1625-1634

  Ellis, Stephen G ^a   O'Shaughnessy, Charles D ^b   Martin, Steven L ^c   Kent, Kenneth ^d   McGarry, Thomas ^e   Turco, Mark A ^f   Kereiakes, Dean J ^g   Popma, Jeffrey J ^h   Friedman, Mark ⁱ   Koglin, Joerg ⁱ   Stone, Gregg W ^j  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Elyria Memorial Hospital   (United States)

^c Nebraska Heart Institute   (United States)

^d WASHINGTON HOSPITAL CENTER   (United States)

^e Oklahoma Heart Hospital   (United States)

^f WASHINGTON ADVENTIST HOSPITAL   (United States)

^g The Carl & Edyth Lindner Center for Research & Education   (United States)

^h ST ELIZABETH'S MEDICAL CENTER   (United States)

ⁱ BOSTON SCIENTIFIC CORPORATION   (United States)

^j NewYork Presbyterian Hospital   (United States)

more..

Author keywords

Brachytherapy; Drug eluting stents; Restenosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; BARE METAL STENT; BRACHYTHERAPY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEATH; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIA; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RESTENOSIS; REVASCULARIZATION; STATISTICAL SIGNIFICANCE; STENT; TAXUS;

AGED; BRACHYTHERAPY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; RISK FACTORS; TREATMENT OUTCOME; TUBULIN MODULATORS;

EID: 46849111727     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn231     Document Type: Article

References (28)

1. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in native coronary artery. N Engl J Med 2003;349:1315- 1323.
2. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME. A polymer-based paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
3. Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, Turco MA, Kereiakes DJ, Kelley L, Popma JJ, Russell ME. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents - the TAXUS V ISR randomized trial. JAMA 2006;295:1253- 1263.
4. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. JACC 2005;45:2088-2092.
5. Pfisterer M, Brunner-La Rocca HB, Buser PT, Rickenbacher P, Hunziker P, Mueller C, Jeger R, Bader F, Osswald S, Kaiser C BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting stents versus baremetal stents. JACC 2006;48:2584-2591.
6. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane A, Cutlip D, Fahy M, Pocock SJ, Mehran R, Leone MB. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008.
7. Mauri L, Hsieh W, Massaro JM, Ho KKL, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-1029.
8. McBride W, Lange RA, Hillis LD. Restenosis after successful coronary angioplasty. Pathophysiology and prevention. N Engl J Med 1988;318:1734-1778.
9. Strauss BH, Umans VA, van Suylen RJ, de Feyter PJ, Marco J, Robertson GC, Renkin J, Heyndrickx G, Vuzevski VD, Bosman FT. Directional atherectomy for treatment of restenosis within coronary stents: clinical, angiographic and histologic results. JACC 1992;20:1465-1473.
10. Teirstein PS, Massullo V, Jani S, Popma JJ, Mintz GS, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Morris NB, Leon MB, Tripuraneni P. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997;336:1697-1703.
11. Leon MB, Teirstein PS, Moses JW, Tripuraneni P, Lansky AJ, Jani S, Wong SC, Fish D. Ellis S, Holmes DR, Kerieakes D, Kuntz RE. Localized intracoronary γ-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001;344:250-256.
12. Waksman R, Raizner AE, Yeung AC, Lansky AJ, Vandertie L. Use of localized intracoronary β radiation in treatment of in-stent restenosis: the INHIBIT randomized controlled trial. Lancet 2002;359:551-557.
13. 90Y β-radiation versus placebo control for treatment of in-stent restenosis. Circulation 2002;106:1090- 1096.
14. Teirstein PS, Massullo V, Jani S, Russo RJ, Cloutier DA, Schatz RA, Guarneri EM, Steuterman S, Sirkin K, Norman S, Tripuraneni P. Two-year follow-up after catheter-based radiotherapy to inhibit coronary restenosis. Circulation 1999;99:243-247.
15. Teirstein PS, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Sirkin K, Cloutier DA, Leone MB, Tripuraneni P. Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 2000;101:360-365.
16. Grise MA, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Cloutier DA, Leon MB, Tripuraneni P, Teirstein PS. Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 2002;105:2737-2740.
17. Waksman R, White RL, Chan RC, Bass BG, Geirlach L, Mintz GS, Satler LF, Mehran R, Serruys PW, Lansky AJ, Fitzgerald P, Bhargava B, Kent KM, Pichard AD, Leon MB. Intracoronary radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000;101:2165- 2171.
18. Leon MB, Tierstein PS, Moses JW, Joseph GA, Wong CS, Holmes DR, Kuntz RE, Lansky A. Declining long-term efficacy of vascular brachytherapy for in-stent restenosis: 5-year follow-up from the Gamma-1 randomized trial. Am J Cardiol 2004;94:144E.
19. Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, Turco MA, Kereiakes DJ, Kelley L, Popma JJ, Russell ME. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents - the TAXUS V ISR randomized trial. JAMA 2006;295:1253- 1263.
20. Holmes DR Jr, Teirstein P, Satler L, Sketch M, O'Malley J, Popma JJ, Kuntz RE, Fitzgerald PJ, Wang H, Caramanica E, Cohen SA SISR Investigators. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized Trial. JAMA 2006;295:1264-1273.
21. Shirai K, Lansky AJ, Mintz GS, Costantini CO, Fahy M, Mehran R, Dangas G, Moses JW, Stone GW, Waksman R, Leon MB. Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosis. Am J Cardiol 2003;92:1409-1413.
22. Costa MA, Sabat M, van der Giessen WJ, Kay P, Cervinka P, Ligthart J, Serrano P, Coen V, Levendag PC, Serruys PW. Late coronary occlusion after intracoronary brachytherapy. Circulation 1999;100:789-792.
23. Mauri L, Hsieh W, Massaro JM, Ho KKL, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-1029.
24. Ruygrok PN, Melkert R, Morel MA, Ormiston JA, Bar FW, Fernandez-Aviles F, Suryapranata H, Dawkins KD, Hanet C, Serruys PW. Does angiography six months after coronary intervention influence management and outcome? Benestent II Investigators. JACC 1999;34:1507-1511.
25. Price MJ, Moses JW, Leon MB, Mehran R, Negoita M, Lansky A, Collins M, Giap H, Lin R, Jani S, Steuterman S, Balter S, Dalton J, Lipsztein R, Tripuraneni P, Teirstein PS. A multicenter, randomized, dose-finding study of gamma intracoronary radiation therapy to inhibit recurrent restenosis after stenting. J Invasive Cardiol 2006;18:169-173.
26. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg G, Morel M, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MK, Serruys PW. Clinical endpoints in coronary stent trials - a case for standardized definitions. Circulation 2007;115:2344-2351.
27. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Bohm M, Speck U. Treatment of coronary in-stent restenosis with paclitaxel-coated balloon catheter. N Engl J Med 2006;355:2113-2124.
28. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999;100:1872-1878.